Skip to main content

Menu

Select a tool from the sidebar

Create your free account now!

Sign in to customize and use tools on the sidebar.

ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş. logo
ANGEN
ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş.
12:35:34
10.61
-0.020 (%-0.19)
Previous Close: 10.63·
Volatility: 1.130
Day Low10.56
Day High10.68
Bid10.6
Ask10.61

Market Data

Spot Rate
B:10.6
A:10.61
Week over week (WoW)
-2.30%
Month over month (MoM)
-4.41%
Year to date (YTD)
-1.85%
Year over year (YoY)
+8.15%

ANGEN: ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş. Stock Live Price Graph

Loading chart...
Industry
BIST
Sector
CHEMICALS\, MEDICINE\, OIL\, TIRE AND PLASTIC
Exchange
Istanbul Stock Exchange
Market
IST

Company profile

BIST code
ANGEN
Employees
249
Field of activity
Moleküler biyoloji alanında kitler, kurulum robotları, yazılımlar ile cihazlar tasarlamak, geliştirmek ve üretmek

Market News & Analysis

Güçlü Sat
Sat
Nötr
Al
Güçlü Al

Target Price

No analyst target price data is available for this instrument.

Dividend History

Cash dividends

Dividend per share
PaymentGross / shareNet / shareYieldPer 1,000 TRY
Jun 11, 2026TRY 0TRY 00%TRY 0
Jun 24, 2025TRY 0TRY 00%TRY 0
May 16, 2024TRY 0TRY 00%TRY 0

Splits & capital actions

Split ratio
Bonus / rights / stock dividend (%)
DateRatioBonus %Rights %Dividend %
May 17, 20232100%0%0%
May 2, 20231.05060%0%119.1611%
Aug 22, 20221.041950%0%138.889%
May 22, 20221.048240%0%138.889%

What Is ANGEN? Live ANGEN Prices and Analysis

ANGEN is a publicly traded company engaged in innovative biotechnology, focusing on the development of advanced therapeutics for various medical conditions. As a key player in the biotech sector, ANGEN has garnered significant attention from investors due to its potential for high returns driven by groundbreaking research and development. The company's progress and market performance are closely monitored by investors who recognize the critical role biotechnology plays in modern healthcare.

Investors follow ANGEN for several reasons, including its unique product pipeline, strategic partnerships, and the overall impact of biotechnology on the economy. The company's advancements can lead to substantial growth opportunities, making it an attractive option within the biotech domain.

Market Context

The biotechnology sector is often characterized by high volatility, influenced by market sentiment, regulatory approvals, and scientific breakthroughs. ANGEN's stock price is typically quoted in U.S. dollars, with trading activities occurring primarily on major exchanges. The company operates in a global context, with international partnerships that can affect its pricing and valuation. Investors should remain aware of the market dynamics that can influence ANGEN’s performance, including currency fluctuations and geopolitical events.

Why Do ANGEN Prices Rise or Fall?

The price of ANGEN stock can be influenced by a variety of factors, reflecting both internal company developments and external market conditions. Understanding these factors is essential for investors looking to make informed decisions.

  • Clinical trial results: Positive or negative outcomes can significantly sway investor confidence.
  • Regulatory approvals: Successful navigation through FDA approvals can enhance stock value.
  • Market competition: Innovations from competitors can impact ANGEN's market position.
  • Partnerships and collaborations: Strategic alliances can bolster resources and credibility.
  • Earnings reports: Quarterly performance can provide insights into the company’s financial health.
  • Market sentiment: Investor perceptions and broader market trends can lead to price fluctuations.
  • Economic indicators: National and global economic conditions can affect investment decisions in biotech.
  • Technological advancements: Breakthroughs in biotechnology can shift investor focus and valuations.

In summary, ANGEN's stock price is subject to a range of influences that can create both opportunities and risks for investors. Staying attuned to these factors is crucial for effective trading strategies.

Why Is Live ANGEN Price Tracking Important?

Live price tracking of ANGEN is essential for investors who wish to capitalize on market movements and make timely decisions. By monitoring real-time data, investors can better assess market conditions and potential entry or exit points.

  • Immediate access to price changes allows for quick decision-making.
  • Understanding volatility helps in managing risk.
  • Live tracking provides insights into market sentiment.
  • Investors can identify trends and patterns in stock performance.
  • Real-time information aids in aligning investment strategies with market conditions.

What Should You Consider When Trading / Investing in ANGEN?

Investing in ANGEN involves certain risks and considerations that investors should be aware of. The biotechnology sector is known for its unpredictability, and ANGEN is no exception.

  • Risk tolerance: Assess your willingness to handle potential losses due to volatility.
  • Macro data: Monitor economic indicators that may impact the biotech industry.
  • Regulatory landscape: Understand the implications of regulatory changes on operations.
  • Market news: Stay informed about developments that could affect stock performance.
  • Diversification: Consider spreading investments across various sectors to mitigate risks.

What Can You Find on the Investvio ANGEN Page?

  • Live price updates for real-time tracking.
  • Comprehensive charts showing historical performance.
  • Technical analysis to guide trading strategies.
  • Latest news and updates related to ANGEN and the biotech sector.
  • In-depth company analysis, including earnings and dividends.

In conclusion, the Investvio ANGEN page serves as a valuable resource for investors seeking to navigate the complexities of the biotechnology market. By utilizing the tools and information available, investors can position themselves to make informed decisions about their ANGEN investments.